Zevra Therapeutics, Inc. (ZVRA)
11.85
+0.11
(+0.94%)
USD |
NASDAQ |
Aug 27, 16:00
11.84
-0.01
(-0.08%)
After-Hours: 20:00
Zevra Therapeutics EPS Diluted (TTM) : 0.927 for June 30, 2026
EPS Diluted (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical EPS Diluted (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 0.927 |
| March 31, 2026 | 2.154 |
| December 31, 2025 | 1.494 |
| September 30, 2025 | 0.6308 |
| June 30, 2025 | -0.0545 |
| March 31, 2025 | -1.894 |
| December 31, 2024 | -2.234 |
| September 30, 2024 | -1.968 |
| June 30, 2024 | -1.572 |
| March 31, 2024 | -1.172 |
| December 31, 2023 | -1.158 |
| September 30, 2023 | -0.5958 |
| June 30, 2023 | -0.489 |
| March 31, 2023 | -1.111 |
| December 31, 2022 | -0.7815 |
| September 30, 2022 | -1.021 |
| June 30, 2022 | -0.8795 |
| March 31, 2022 | -0.5482 |
| December 31, 2021 | -2.988 |
| September 30, 2021 | -3.980 |
| June 30, 2021 | -4.61 |
| March 31, 2021 | -4.026 |
| December 31, 2020 | -3.447 |
| September 30, 2020 | -5.257 |
| Date | Value |
|---|---|
| June 30, 2020 | -3.613 |
| March 31, 2020 | -9.048 |
| December 31, 2019 | -14.50 |
| September 30, 2019 | -14.82 |
| June 30, 2019 | -30.82 |
| March 31, 2019 | -40.16 |
| December 31, 2018 | -61.12 |
| September 30, 2018 | -69.44 |
| June 30, 2018 | -65.28 |
| March 31, 2018 | -57.76 |
| December 31, 2017 | -47.20 |
| September 30, 2017 | -46.56 |
| June 30, 2017 | -50.40 |
| March 31, 2017 | -52.64 |
| December 31, 2016 | -38.08 |
| September 30, 2016 | -37.44 |
| June 30, 2016 | -33.60 |
| March 31, 2016 | -63.52 |
| December 31, 2015 | -100.32 |
| September 30, 2015 | -104.15 |
| June 30, 2015 | -93.27 |
| March 31, 2015 | -54.07 |
| December 31, 2014 | -14.07 |
EPS Diluted (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (TTM) Benchmarks
| Innoviva, Inc. | 4.105 |
| Collegium Pharmaceutical, Inc. | 1.234 |
| Johnson & Johnson | 8.628 |
| Ligand Pharmaceuticals, Inc. | 9.354 |
| Harrow, Inc. | -0.9996 |